Jambrovics, K., Balajthy, Z.: ATRA and ATO combination has several beneficial effects in treatment of Acute Promyelocytic Leukaemia cells.
In: 15th Molecular, Cell and Immune Biology Winter Symposium : Book of abstract, University of Debrecen, Debrecen, 25, 2022.

Vámos, A., Shaw, A., Varga, K., Csomós, I., Mocsár, G., Balajthy, Z., Lányi, C., Bacsó, Z., Szatmári-Tóth, M., Kristóf, E.: Mitophagy Mediates the Beige to White Transition of Human Primary Subcutaneous Adipocytes Ex Vivo.
Pharmaceuticals (Basel). 15 (3), 1-21, 2022.

Kenesei, Á., Volkó, J., Szalóki, N., Mocsár, G., Jambrovics, K., Balajthy, Z., Dóczy-Bodnár, A., Tóth, K., Waldmann, T., Vámosi, G.: IL-15 Trans-Presentation Is an Autonomous, Antigen-Independent Process.
J. Immunol. 207 (10), 2489-2500, 2021.

Shaw, A., Szatmári-Tóth, M., Csomós, I., Mocsár, G., Balajthy, Z., Győry, F., Kristóf, E., Fésüs, L.: Mitophagy is downregulated upon thermogenic stimulus in human beige adipocytes.
FEBS Open Bio. 11 (S1), 9, 2021.

Jambrovics, K., Uray, I., Keillor, J., Fésüs, L., Balajthy, Z.: Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2.
Cancers (Basel). 12 (3), 648-, 2020.

Szatmári-Tóth, M., Shaw, A., Csomós, I., Mocsár, G., Fischer-Posovszky, P., Wabitsch, M., Balajthy, Z., Lányi, C., Győry, F., Kristóf, E., Fésüs, L.: Thermogenic Activation Downregulates High Mitophagy Rate in Human Masked and Mature Beige Adipocytes.
Int. J. Mol. Sci. 21 (18), 1-21, 2020.

Volkó, J., Kenesei, Á., Zhang, M., Várnai, P., Mocsár, G., Petrus, M., Jambrovics, K., Balajthy, Z., Müller, G., Dóczy-Bodnár, A., Tóth, K., Waldmann, T., Vámosi, G.: IL-2 receptors preassemble and signal in the ER/Golgi causing resistance to antiproliferative anti-IL-2R[alfa] therapies.
Proc. Natl. Acad. Sci. U. S. A. 116 (42), 21120-21130, 2019.

Kristóf, E., Klusóczki, Á., Veress, R., Shaw, A., Combi, Z., Varga, K., Győry, F., Balajthy, Z., Bai, P., Bacsó, Z., Fésüs, L.: Interleukin-6 released from differentiating human beige adipocytes improves browning.
Exp. Cell Res. 377 (1-2), 47-55, 2019.

Jambrovics, K., Uray, I., Keresztessy, Z., Keillor, J., Fésüs, L., Balajthy, Z.: Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-kB activation.
Haematol-Hematol. J. 104 (3), 505-515, 2019.

Kristóf, E., Doan-Xuan, Q., Sárvári, A., Klusóczki, Á., Fischer-Posovszky, P., Wabitsch, M., Bacsó, Z., Bai, P., Balajthy, Z., Fésüs, L.: Clozapine modifies the differentiation program of human adipocytes inducing browning.
Transl. Psychiatry. 6 (11), 1-12, 2016.

Csomós, K., Kristóf, E., Márkus, B., Csomós, I., Kovács, G., Rotem, O., Hodrea, J., Bagoly, Z., Muszbek, L., Balajthy, Z., Csősz, É., Fésüs, L.: Protein cross-linking by chlorinated polyamines and transglutamylation stabilizes neutrophil extracellular traps.
Cell Death Dis. 7 (8), e2332, 2016.

Sárvári, A., Doan-Xuan, Q., Bacsó, Z., Csomós, I., Balajthy, Z., Fésüs, L.: Interaction of differentiated human adipocytes with macrophages leads to trogocytosis and selective IL-6 secretion.
Cell Death Dis. 6 e1613, 2015.

Sárvári, A., Veréb, Z., Uray, I., Fésüs, L., Balajthy, Z.: Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro.
Biochem. Biophys. Res. Commun. 450 (4), 1383-1389, 2014.

Doan-Xuan, Q., Sárvári, A., Fischer-Posovszky, P., Wabitsch, M., Balajthy, Z., Fésüs, L., Bacsó, Z.: High content analysis of differentiation and cell death in human adipocytes.
Cytom. Part A. 83 (10), 933-943, 2013.

Kristóf, E., Doan-Xuan, Q., Sárvári, A., Balajthy, Z., Bacsó, Z., Fésüs, L.: Second generation antipsychotic (SGA) drugs modify the differentiation program of human adipocytes inducing 'browning' markers.
FEBS J. 280 (1), 289, 2013.

Aradi, J., Balajthy, Z., Csősz, É., Scholtz, B., Szatmári, I., Tőzsér, J., Varga, T.: Molecular therapies.
University of Debrecen, Debrecen, 120 p., 2011.

Aradi, J., Balajthy, Z., Csősz, É., Scholtz, B., Szatmári, I., Tőzsér, J., Varga, T.: Molekuláris terápiák.
Debreceni Egyetem, Debrecen, 112 p., 2011.

Csomós, K., Német, I., Fésüs, L., Balajthy, Z.: Tissue transglutaminase contributes to the all-trans retinoic acid induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia.
Blood. 116 (19), 3933-3943, 2010.

Széles, L., Keresztes, G., Töröcsik, D., Balajthy, Z., Krenács, L., Póliska, S., Steinmeyer, A., Zuegel, U., Pruenster, M., Rot, A., Nagy, L.: 1,25 dihidroxyvitamin D3 Is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype.
J. Immunol. 182 (4), 2047-2083, 2009.

Sarang, Z., Tóth, B., Balajthy, Z., Köröskényi, K., Garabuczi, É., Fésüs, L., Szondy, Z.: Some lessons from the tissue transglutaminase knockout mouse.
Amino Acids. 36 (4), 625-631, 2009.

Tóth, B., Garabuczi, É., Sarang, Z., Vereb, G., Vámosi, G., Aeschlimann, D., Blaskó, B., Bécsi, B., Erdődi, F., Lacy-Hulbert, A., Zhang, A., Falsca, L., Birge, R., Balajthy, Z., Melino, G., Fésüs, L., Szondy, Z.: Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells.
J. Immunol. 182 (4), 2084-2092, 2009.

Balajthy, Z.: Synthesis and Evaluation of Macromolecule-Bound Derivatives of a Peptidyl-1-béta-D-arabinofuranosylcytosine Prodrug.
Drug Metab. Lett. 2 (2), 83-89, 2008.

Keresztessy, Z., Csősz, É., Hársfalvi, J., Csomós, K., Gray, J., Lightowlers, R., Lakey, J., Balajthy, Z., Fésüs, L.: Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2.
Protein Sci. 15 (11), 2466-2480, 2006.

Balajthy, Z., Csomós, K., Vámosi, G., Szántó, A., Lanotte, M., Fésüs, L.: Tissue-transglutaminase contributes to neutrophil granulocyte differentiation and functions.
Blood. 108 (6), 2045-2054, 2006.

Benoit, G., Flexor, M., Besançon, F., Altucci, L., Rossin, A., Hillion, J., Balajthy, Z., Legres, L., Ségal-Bendirdjian, E., Gronemeyer, H., Lanotte, M.: Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells.
Mol. Endocrinol. 15 (7), 1154-1169, 2001.